六西格玛在传染病血清学质控中应用的循证评估
本文比较并批判性综述了四项将西格玛度量应用于传染病血清学检测的研究,这些研究在计算不精密度和偏倚的方法上存在差异,且均使用质控均值与检测临界值之差描述总允许误差。基于澳大利亚国家血清学参考实验室QConnect质控项目的真实数据评估发现,西格玛度量的应用缺乏标准化,存在不恰当假设。Westgard西格玛规则建议西格玛值≥6的检测可使用两项质控措施和单规则(均值±3SD)监测,但证据表明该方法仍可能漏检真实误差。
要点
- 四项研究在传染病血清学西格玛计算中方法不一致,缺乏标准化。
- Westgard西格玛规则建议西格玛≥6时用两项质控和1-3s规则监测。
- 即使采用简化规则,仍可能漏检真实误差。
核心结论
- 传染病血清学检测中六西格玛度量的应用缺乏标准化,存在不恰当假设。
- Westgard西格玛规则建议西格玛值≥6的检测可使用两项质控措施和单规则(均值±3SD)监测,但该方法仍可能漏检真实误差。
研究设计与样本
- 本文比较并批判性综述了四项将西格玛度量应用于传染病血清学检测的研究。
- 三项研究在血库环境中应用西格玛度量,一项在诊断实验室使用抗弓形虫检测。
- 一项研究针对微孔板酶免疫分析,三项针对全自动化学发光分析。
- 使用澳大利亚国家血清学参考实验室QConnect质控项目的真实质控数据进行循证评估。
主要发现
- 四项研究在计算不精密度(以变异系数百分比表示)和偏倚的方法上存在差异。
- 所有四项研究均使用质控结果均值与检测临界值之差描述总允许误差。
- 评估发现西格玛度量的应用缺乏标准化,包括使用不恰当假设的例子。
关键数值与推荐
- Westgard西格玛规则建议西格玛值≥6的检测可使用两项质控措施和单规则(均值±3SD)监测。
- 四项研究均使用质控均值与检测临界值之差作为总允许误差。
临床怎么用
- 对于西格玛值≥6的传染病血清学检测,可考虑采用两项质控措施和1-3s规则监测。
- 需注意简化质控规则可能漏检真实误差,应结合其他质量保证措施。
局限性
- 评估基于四项研究方法比较和NRL QConnect质控数据,可能受限于研究间异质性。
- 未报告具体样本量、P值等统计细节。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Recently, four publications have applied Sigma metrics to infectious disease serology testing. Three studies applied Sigma metrics to assays in a blood bank setting, whereas one used anti-toxoplasma testing in a diagnostic laboratory. One of the four studies applied the approach to microtitre plate enzyme immunoassays, whereas the other three were on fully automated chemiluminescent assay. The approaches used by each study differed in the approach used to calculate imprecision, measured as a percentage coefficient of variation, and bias. All four studies used the difference between the mean of the quality control result and the assay cut-off to describe the total allowable error. METHODS: This paper compares and critically reviews the methods used to calculate the Sigma value for each assay in the four studies and provides an evidence-based assessment of these approaches using real-world quality control data obtained from the National Serology Reference Laboratory, Australia (NRL) QConnect™ quality control program. RESULTS: The assessment found that there was a lack of standardisation in the application of Sigma metrics for infectious disease testing, including examples of inappropriate assumptions being used. Westgard Sigma Rules suggest that assays found to have a Sigma value of six or greater can be monitored using two quality control measures and applying a single mean ± three standard deviation rule. CONCLUSIONS: Although this approach will significantly reduce the number of false rejections generated by using the full range of Westgard rules, we provide evidence that even this approach can potentially cause true errors to be missed.
引用
- Dimech W, Vincini G. Evidence-based assessment of the application of Six Sigma to infectious disease serology quality control. Clin Chem Lab Med. 2025. PMID: 39964186. doi:10.1515/cclm-2024-1455
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。